SRBM Team includes multiple licensed patent attorneys qualified to handle civil and administrative IP disputes in mainland China, providing solid legal support for intellectual property conflicts. Furthermore, former examiners from the CNIPA contribute their in-depth understanding of China’s patentability standards and examination practices, ensuring precise and efficient professional guidance. The SRBM Team consists of experts with deep expertise across the life sciences, including antibodies, cell therapies, gene editing and gene therapies, ADCs and other conjugates, peptides, fusion proteins, nucleic-acid therapeutics, small-molecule drugs, and drug-delivery technologies. 

We support clients throughout the entire patent lifecycle, offering:

• Global patent portfolio strategy and management

• Patent drafting and prosecution

• Reexamination and invalidation proceedings

• IP litigation in mainland China